The Eastern Europe molecular diagnostics market is undergoing a gradual yet transformative phase, driven by increasing prevalence of infectious and chronic diseases, a shift toward personalized medicine, and the gradual modernization of healthcare infrastructure across the region. Valued at US$ 1.1 Bn in 2024, the market is projected to grow at a CAGR of 3.2% from 2025 to 2035, reaching approxim..